AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(3), 2001, pp. 193-196
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundar, S
Right arrow Articles by Kenney, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sundar, S
Right arrow Articles by Kenney, R.
Related Collections
Right arrow Travel Medicine
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 3, 193-196
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Resistance to treatment in Kala-azar: speciation of isolates from northeast India

S Sundar, K Pai, R Kumar, K Pathak-Tripathi, AA Gam, M Ray, and RT Kenney

Kala-azar in India is becoming increasingly difficult to treat, which may be due to the presence of species other than Leishmania donovani; Leishmania tropica was reported to cause the same clinical syndrome in the area. Over the past 3 years, we have collected samples from 241 patients with visceral leishmaniasis from across the region. Of the 189 isolates that grew on diphasic medium, 159 were successfully transferred to liquid medium for typing. Clinically, 80% of these were resistant to antimony. Lipophosphoglycan-specific monoclonal antibodies were used to distinguish the 2 species by agglutination of promastigotes; all 159 were shown to be L. donovani. Eighty-three isolates were confirmed to be L. donovani by isoenzyme analysis, by amplification of kinetoplast DNA, or both, in comparison with multiple reference strains; none were L. tropica. Thus, the rising incidence of clinical resistance to treatment is unlikely to be due to a different species causing kala-azar in north Bihar.


This article has been cited by other articles:


Home page
 Eukaryot CellHome page
C. Dumas, C. Chow, M. Muller, and B. Papadopoulou
A Novel Class of Developmentally Regulated Noncoding RNAs in Leishmania
Eukaryot. Cell, December 1, 2006; 5(12): 2033 - 2046.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
S. L. Croft, S. Sundar, and A. H. Fairlamb
Drug Resistance in Leishmaniasis
Clin. Microbiol. Rev., January 1, 2006; 19(1): 111 - 126.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Breton, M. J Tremblay, M. Ouellette, and B. Papadopoulou
Live Nonpathogenic Parasitic Vector as a Candidate Vaccine against Visceral Leishmaniasis
Infect. Immun., October 1, 2005; 73(10): 6372 - 6382.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. M. ALLAHVERDIYEV, M. BAGIROVA, S. UZUN, D. ALABAZ, N. AKSARAY, E. KOCABAS, and F. KOKSAL
THE VALUE OF A NEW MICROCULTURE METHOD FOR DIAGNOSIS OF VISCERAL LEISHMANIASIS BY USING BONE MARROW AND PERIPHERAL BLOOD
Am J Trop Med Hyg, August 1, 2005; 73(2): 276 - 280.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. Schulz, K. Mellenthin, G. Schonian, B. Fleischer, and C. Drosten
Detection, Differentiation, and Quantitation of Pathogenic Leishmania Organisms by a Fluorescence Resonance Energy Transfer-Based Real-Time PCR Assay
J. Clin. Microbiol., April 1, 2003; 41(4): 1529 - 1535.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. Sundar and M. Rai
Laboratory Diagnosis of Visceral Leishmaniasis
Clin. Vaccine Immunol., September 1, 2002; 9(5): 951 - 958.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.